AF
BIOA

Allworth Financial’s BioAge Labs BIOA Stock Holding History

Allworth Financial’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$193 Buy
+11
New +$212 ﹤0.01% 4930

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Allworth Financial's BIOA Position: Q1 2026 in Review

Allworth Financial opened a new position in BioAge Labs (BIOA) in Q1 2026: 11 shares worth $193. The stake represents ﹤0.01% of the portfolio and ranks #4930 among its holdings.

144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Allworth Financial held 11 shares of BioAge Labs worth $193 as of Q1 2026.
  • BioAge Labs was a new Allworth Financial position in Q1 2026.
  • BioAge Labs made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #4930 holding.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.